Flavia Borellini's Insider Trades & SAST Disclosures
Flavia Borellini's most recent trade in Viracta Therapeutics Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Flavia Borellini.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viracta Therapeutics Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,955 | 15,955 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,800 | 22,434 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,248 | 21,882 (0%) | 0% | 0 | Common Stock | |
| Viracta Therapeutics Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 5,200 | 17,634 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 5,200 | 12,434 (0%) | 0% | 0 | Common Stock | |
| Viracta Therapeutics Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Viracta Therapeutics Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 25,318 | 25,318 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 7,234 | 7,234 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges